Yamamoto Yoshiaki 山本義明

Researcher Number	30593298
Other IDs
Affiliation (based on the past Project Information) *help	2020 – 2022: 山口大学, 医学部, 特別医学研究員 2016 – 2020: 山口大学, 医学部附属病院, 助教
Review Section/Research Field	Principal Investigator Basic Section 56030:Urology-related Except Principal Investigator Basic Section 56030:Urology-related / Urology
Keywords	Principal Investigator 遺伝子チップ / アルゴリズム / 治療効果予測 / 泌尿器癌 / ミスマッチ修復蛋白 / 消化管内マイクロバイオーム / 口腔内マイクロバイオーム / ミスマッチ修復遺伝子 / マイクロサテライト不安定性 / 腎細胞癌 / 尿路上皮癌 / 抗PD-1抗体 … More Except Principal Investigator … More 薬剤感受性試験 / がん免疫環境ニッチ / 3Dがんオルガノイド / 筋層浸潤性 / 免疫逃避 / 薬剤感受性 / 3次元培養 / 癌微小環境 / 癌オルガノイド / 膀胱癌 / 薬剤選択マーカー / リキッドバイオプシー / ３Ｄオルガノイド / ARHGAP18 / バイオマーカー / 前立腺癌 / ARHGAP29 / YAP / 神経内分泌癌 / 3Dオルガノイド / 去勢抵抗性前立腺癌 Less

Development of a bladder cancer drug-sensitivity platform based on cancer niche formation including immune cell components
- Principal Investigator
  
  Matsumoto Hiroaki
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Yamaguchi University
MSI related predictive biomarkers of response to immune checkpoint inhibitors for patients with metastatic urological cancersPrincipal Investigator
- Principal Investigator
  
  Yamamoto Yoshiaki
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Yamaguchi University
Development of novel markers for drug screening and descovery of mechanism to neuroendocrine differentiation in castration resistant prostate cancer
- Principal Investigator
  
  MATSUMOTO Hiroaki
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  Yamaguchi University

All 2021 2020 2019

All Journal Article Presentation Book

[Book] 特集膀胱癌 -最近の診断と治療-：尿路上皮癌における免疫チェックポイント阻害薬の予後予測因子2021
- Author(s)
  山本義明, 松山豪泰
- Total Pages
  118
- Publisher
  日本臨牀
- Data Source
  KAKENHI-PROJECT-19K09730
[Journal Article] 転移性尿路上皮癌に対する免疫チェックポイント阻害剤の治療効果について2020
- Author(s)
  山本義明、栗林智枝子、小澤翔、佐本征弘、森純一、井上亮、矢野誠司、平田寛、松本洋明　松山豪泰
- Journal Title
  
  西日本泌尿器科
  
  Volume: 82 Pages: 61-65
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K09730
[Journal Article] Prognostic value of pre-treatment risk stratification and post-treatment neutrophil/lymphocyte ratio change for pembrolizumab in patients with advanced urothelial carcinoma2020
- Author(s)
  Yoshiaki Yamamoto, Junji Yatsuda, Mototsugu Shimokawa, Nakanori Fuji, Akihiko Aoki, Shigeru Sakano, Mitsutaka Yamamoto, Akinobu Suga, Yasuhide Tei, Satoru Yoshihiro, Seiji Kitahara, Kazuhiro Nagao, Kimio Takai, Yoriaki Kamiryo, Jumpei Akao, Shiro Yamaguchi, Kazuo Oba, Tomoyuki Shimabukuro, Hiroaki Matsumoto, et al
- Journal Title
  
  International Journal of Clinical Oncology
  
  Volume: 26 Issue: 1 Pages: 169-177
- DOI
  10.1007/s10147-020-01784-w
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K09730
[Journal Article] Prognostic value of risk stratification using blood parameters for nivolumab in Japanese patients with metastatic renal-cell carcinoma2019
- Author(s)
  Yamamoto Yoshiaki、Matsuyama Hideyasu、Matsumoto Hiroaki、Sakano Shigeru、Fuji Nakanori、Oba Kazuo、Yamamoto Mitsutaka、Kamiryo Yoriaki、Hiragino Takeshi、Nagao Kazuhiro、Takai Kimio、Aoki Akihiko
- Journal Title
  
  Japanese Journal of Clinical Oncology
  
  Volume: 50 Issue: 2 Pages: 214-220
- DOI
  10.1093/jjco/hyz168
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K09730
[Presentation] 尿サンプル由来ヒト膀胱がんオルガノイド培養法の確立2021
- Author(s)
  藤坂航大、モハメドエルダウィ、佐藤よもぎ、山本晴、松本洋明、松山豪泰、金田正弘、臼井達哉、佐々木一昭
- Organizer
  第94回日本薬理学会年会
- Data Source
  KAKENHI-PROJECT-20K09527
[Presentation] Prognostic value of risk stratification using blood biochemical parameters in Japanese patients with metastatic renal cell carcinoma treated by nivolumab2020
- Author(s)
  Yoshiaki Yamamoto, Hideyasu Matsuyama, Hiroaki Matsumoto, Shigeru Sakano, Nakanori Fuji, Kazuo Oba, Mitsutaka Yamamoto, Yoriaki Kamiryo, Takeshi Hiragino, Kazuhiro Nagao, Kimio Takai, Akihiko Aoki
- Organizer
  Genitourinary Cancers Symposium - ASCO Meetings
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K09730
[Presentation] ニボルマブにて治療された転移性腎細胞癌に対する血液検査を用いたリスク分類と予後予測2020
- Author(s)
  山本義明、小澤　翔、佐本　征弘、森　純一、井上　亮、矢野　誠司、平田　寛、松本　洋明、松山　豪泰
- Organizer
  第58回日本癌治療学会学術集会
- Data Source
  KAKENHI-PROJECT-19K09730
[Presentation] 転移性尿路上皮癌に対する免疫チェックポイント阻害剤の臨床的因子による治療効果予測2020
- Author(s)
  山本義明、松山豪泰
- Organizer
  第24回日本がん免疫学会総会
- Invited
- Data Source
  KAKENHI-PROJECT-19K09730
[Presentation] 尿路上皮癌に対する免疫チェックポイント阻害剤の分子生物学的考慮2019
- Author(s)
  山本義明
- Organizer
  第71回西日本泌尿器科学会総会
- Invited
- Data Source
  KAKENHI-PROJECT-19K09730

1. 松山豪泰 (70209667)

# of Collaborated Projects: 3 results

# of Collaborated Products: 7 results
2. MATSUMOTO Hiroaki (60610673)

# of Collaborated Projects: 2 results

# of Collaborated Products: 1 results
3. 清木誠 (50226619)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
4. 恒富亮一 (10420514)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
5. 藤田悠介 (40509527)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. 硲彰一 (50253159)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. 平田寛 (40781307)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

Yamamoto Yoshiaki 山本 義明

Research Projects

Research Products

Co-Researchers

Development of a bladder cancer drug-sensitivity platform based on cancer niche formation including immune cell components

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

MSI related predictive biomarkers of response to immune checkpoint inhibitors for patients with metastatic urological cancersPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of novel markers for drug screening and descovery of mechanism to neuroendocrine differentiation in castration resistant prostate cancer

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Book] 特集 膀胱癌 -最近の診断と治療-：尿路上皮癌における免疫チェックポイント阻害薬の予後予測因子2021

Author(s)

Total Pages

Publisher

Data Source

[Journal Article] 転移性尿路上皮癌に対する免疫チェックポイント阻害剤の治療効果について2020

Author(s)

Journal Title

Data Source

[Journal Article] Prognostic value of pre-treatment risk stratification and post-treatment neutrophil/lymphocyte ratio change for pembrolizumab in patients with advanced urothelial carcinoma2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Prognostic value of risk stratification using blood parameters for nivolumab in Japanese patients with metastatic renal-cell carcinoma2019

Author(s)

Journal Title

DOI

Data Source

[Presentation] 尿サンプル由来ヒト膀胱がんオルガノイド培養法の確立2021

Author(s)

Organizer

Data Source

[Presentation] Prognostic value of risk stratification using blood biochemical parameters in Japanese patients with metastatic renal cell carcinoma treated by nivolumab2020

Author(s)

Organizer

Data Source

[Presentation] ニボルマブにて治療された転移性腎細胞癌に対する血液検査を用いたリスク分類と予後予測2020

Author(s)

Organizer

Data Source

[Presentation] 転移性尿路上皮癌に対する免疫チェックポイント阻害剤の臨床的因子による治療効果予測2020

Author(s)

Organizer

Data Source

[Presentation] 尿路上皮癌に対する免疫チェックポイント阻害剤の分子生物学的考慮2019

Author(s)

Organizer

Data Source

Yamamoto Yoshiaki 山本義明

[Book] 特集膀胱癌 -最近の診断と治療-：尿路上皮癌における免疫チェックポイント阻害薬の予後予測因子2021